Acute Serious Thrombocytopenia Associated with Intracoronary Tirofiban Use for Primary Angioplasty
Tirofiban, a specific glycoprotein IIb/IIIa inhibitor, may cause extensive thrombocytopenia with an incidence of 0.2% to 0.5%. We report the case of a 50-year-old man who developed thrombocytopenia after tirofiban use (both intracoronary and peripheral) over hours and the successful management of th...
Saved in:
| Main Authors: | Mustafa Yurtdaş, Yalin Tolga Yaylali, Nesim Aladağ, Mahmut Özdemir, Memiş Hilmi Atay |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | Case Reports in Medicine |
| Online Access: | http://dx.doi.org/10.1155/2014/190149 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Severe Acute Thrombocytopenia After Treatment with Tirofiban: A Case Series Approach
by: Gian-Manuel Jiménez-Rodríguez, et al.
Published: (2023-04-01) -
Role of Intracoronary Imaging in Acute Coronary Syndromes
by: Gregory Petrossian, et al.
Published: (2022-06-01) -
A Case of Hyperacute Severe Thrombocytopenia Occurring Less than 24 Hours after Intravenous Tirofiban Infusion
by: Vineet Meghrajani, et al.
Published: (2018-01-01) -
SAFETY OF TIROFIBAN FOR PATIENTS WITH ACUTE ISCHEMIC STROKE IN ROUTINE CLINICAL PRACTICE
by: Yan-Jun Zhang, et al.
Published: (2014-04-01) -
Antiplatelet medications in acute coronary syndromes and percutaneous coronary interventions: focus on tirofiban
by: T. A. Batyraliev, et al.
Published: (2008-12-01)